NGNE Neurogene Inc. - Common Stock
NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 11, 2026
$25,65
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$16,30minimo 52 sett.
$43,66massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$406M
P/E
-6.1
EPS
$-4.24
Ricavi
$0
i tuoi badge
Intervallo 52 sett.
$16–$44
Rating Analisti
BUY
Prezzo Obiettivo
$80
P/E
-6.1
ROE
-33.6%
Margine di Profitto Netto
·
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
NGNE Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$25.65
Capitalizzazione di Mercato (MRQ)
$406M
P/E
-6.1
EPS
$-4.24
Ricavi
$0
ROE
-33.6%
Intervallo 52 sett.
$16–$44
NGNE Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Split azionari
| Data ex-dividendo | Split | Tipo |
|---|---|---|
| 19 Dicembre 2023 | 1-for-4 | Inverso |
| 25 Settembre 2023 | 1-for-5 | Inverso |
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$02018-12-31 → 2025-12-31
EPS$-4.242020-12-31 → 2025-12-31
Flusso di cassa libero$-78M2016-12-31 → 2025-12-31
Margine netto·2022-12-31 → 2024-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | NGNE | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E | -6.1media 5 anni ≈-21.6 | ≈-21.6 | · | · | |
| P/B (MRQ) | 1.9media 5 anni ≈7.4 | ≈7.4 | 2.9 | Sottovalutato | |
| Prezzo / FCF (TTM) | -4.6media 5 anni ≈-20.7 | ≈-20.7 | · | · | |
| Prezzo / Flusso di cassa (TTM) | -4.7media 5 anni ≈-21.9 | ≈-21.9 | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 1.5media 5 anni ≈1.2 | ≈1.2 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | NGNE | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| ROA | -28.9%media 5 anni ≈-30.3% | ≈-30.3% | -17.8% | Debole | |
| ROE | -33.6%media 5 anni ≈-549.1% | ≈-549.1% | -18.7% | Debole | |
| ROIC | -39.0% | · | -32.5% | Debole |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | NGNE | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 10.6media 5 anni ≈14.4 | ≈14.4 | 11.6 | Bassa liquidità | |
| Quick Ratio | 16.4media 5 anni ≈14.2 | ≈14.2 | 2.9 | Liquidità elevata |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | NGNE | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 0.0media 5 anni ≈0.0 | ≈0.0 | 0.0 | Debole | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$0.00 | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
5.9%
Prossimo report
Nov 11, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 10, 2026 | $-1.53 | $-1.45 | -5.4% |
| 31 Marzo 2026 | Mag 8, 2026 | $-1.39 | $-1.32 | -5.1% |
| 31 Dicembre 2025 | $-1.17 | $-1.21 | 3.5% | |
| 30 Settembre 2025 | $-0.99 | $-1.27 | 22.4% | |
| 30 Giugno 2025 | $-1.05 | $-1.18 | 11.1% | |
| 31 Marzo 2025 | $-1.08 | $-1.08 | 0.42% | |
| 31 Dicembre 2024 | $-0.99 | $-1.15 | 14.1% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $925.0K | $0 | · | · | · | · | $25M | |
| R&D Expense | $75M | $61M | $44M | $48M | $39M | · | · | $42M | |
| SG&A Expense | $28M | $23M | $11M | $9M | $22M | $17M | $19M | $16M | |
| Operating Expenses | $103M | $84M | $56M | $57M | $61M | · | $71M | $58M | |
| Operating Income | $-103M | $-83M | $-56M | $-57M | $-61M | $-34M | $-71M | $-33M | |
| Interest Expense | · | · | $12.0K | $2.0K | · | · | $1.0K | $4.0K | |
| Interest Income | $12M | $8M | $3M | $1M | · | · | · | · | |
| Other Non-op | $13M | $7M | · | $-42.0K | $-13.0K | $-44.0K | $-9.0K | $1M | |
| Pretax Income | $-90M | $-75M | $-36M | $-55M | $-61M | $-33M | $-69M | $-32M | |
| Income Tax | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $-90M | $-75M | $-36M | $-55M | $-61M | $-33M | $-69M | $-32M | |
| EPS (Basic) | $-4.24 | $-4.28 | · | $-1.04 | $-1.10 | $-0.64 | · | · | |
| EPS (Diluted) | $-4.24 | $-4.28 | · | $-1.04 | $-1.10 | $-0.64 | · | · | |
| Shares (Basic) | 21,326,283 | 17,567,082 | · | 55,221,161 | 55,041,662 | 51,825,022 | · | · | |
| Shares (Diluted) | 21,326,283 | 17,567,082 | · | 55,221,161 | 55,041,662 | 51,825,022 | · | · | |
| EBITDA | $-100M | $-79M | $-52M | $-58M | $-59M | $-33M | $-71M | · |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $104M | $137M | $148M | $82M | $142M | $193M | $143M | $77M | |
| Short-term Investments | $165M | $176M | $49M | $0 | $0 | · | · | · | |
| Prepaid Expense | $3M | $4M | $3M | $3M | · | · | · | · | |
| Other Current Assets | $168.0K | $981.0K | $1M | $630.0K | $2M | $2M | $503.0K | · | |
| Current Assets | $272M | $316M | $200M | $85M | $144M | $195M | $144M | $77M | |
| PP&E (Net) | $13M | $15M | $17M | $20M | $6M | $4M | $2M | $400.0K | |
| PP&E (Gross) | $27M | $27M | $25M | $25M | · | $4M | $3M | $843.0K | |
| Accum. Depreciation | $14M | $11M | $8M | $5M | · | $585.0K | $688.0K | $443.0K | |
| Intangibles | · | · | · | $0 | $128.0K | $347.0K | $567.0K | · | |
| Other Non-current Assets | $1M | $975.0K | $764.0K | $0 | $2M | $2M | $30.0K | · | |
| Total Assets | $289M | $336M | $223M | $109M | $163M | $211M | $147M | $78M | |
| Accounts Payable | $2M | $1M | $3M | $625.0K | $7M | $7M | $4M | · | |
| Accrued Liabilities | $11M | $10M | $17M | $5M | · | · | · | · | |
| Current Liabilities | $16M | $15M | $23M | $7M | $9M | $8M | $5M | $5M | |
| Capital Leases | $7M | $9M | $12M | $4M | $12M | $11M | $447.0K | $6.0K | |
| Other Non-current Liabilities | $51.0K | $51.0K | $203.0K | $0 | · | · | · | $319.0K | |
| Total Liabilities | $24M | $25M | $37M | $11M | $20M | $19M | $5M | $5M | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Paid-in Capital | $618M | $573M | $373M | $5M | $536M | $524M | $441M | $303M | |
| Retained Earnings | $-353M | $-262M | $-187M | $-151M | $-393M | $-333M | $-300M | $-230M | |
| AOCI | · | · | · | $-21.0K | $0 | · | · | · | |
| Stockholders' Equity | $265M | $310M | $186M | $-146M | $-92M | $191M | $142M | $73M | |
| Liabilities + Equity | $289M | $336M | $223M | $109M | $163M | $211M | $147M | $78M | |
| Shares Outstanding | 15,489,800 | 14,854,725 | 12,823,665 | 0 | 0 | 42,196,296 | 37,996,849 | 23,537,368 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $3M | $3M | $1M | $785.0K | $340.0K | $289.0K | |
| Stock-based Comp | $14M | $8M | $1M | $1M | $12M | $6M | $8M | $5M | |
| Amort. of Intangibles | · | · | · | $100.0K | $200.0K | $200.0K | · | · | |
| Restructuring | · | · | · | $1M | · | $0 | · | · | |
| Other Non-cash | $-4M | $-7M | $-20M | $2M | $271.0K | $2M | $46M | · | |
| Operating Cash Flow | $-77M | $-71M | $-51M | $-53M | $-48M | $-25M | $-15M | $-32M | |
| CapEx | $1M | $808.0K | $321.0K | $2M | $3M | $2M | $879.0K | $49.0K | |
| Investing Cash Flow | $14M | $-125M | $26M | $-2M | $-3M | $-2M | $-688.0K | $56M | |
| Stock Issued | $30M | $0 | $92M | $0 | $0 | $72M | $81M | · | |
| Net Stock Activity | $30M | $0 | $92M | · | $0 | $72M | $86M | · | |
| Financing Cash Flow | $30M | $184M | $92M | $67M | $732.0K | $77M | $82M | $570.0K | |
| Net Change in Cash | $-33M | $-12M | $67M | $11M | $-50M | $50M | $66M | $25M | |
| Free Cash Flow | $-78M | $-71M | $-52M | $-47M | $-51M | $-27M | $-16M | · |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -8930.3% | · | -3735.6% | · | · | · | · | |
| Net Margin | · | -8123.7% | · | -3638.2% | · | · | · | · | |
| Pretax Margin | · | -8123.7% | · | -3639.6% | · | · | · | · | |
| EBITDA Margin | · | -8584.9% | · | -3636.9% | · | · | · | · | |
| ROA | -28.9% | -26.9% | -21.9% | -41.2% | -32.5% | -18.6% | -61.8% | · | |
| ROE | -33.6% | -33.6% | -2580.2% | -57.6% | -40.8% | -17.0% | -66.6% | · | |
| ROIC | -39.0% | · | · | · | · | · | · | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 16.6 | 20.8 | 8.7 | 9.0 | 16.7 | 24.7 | 30.3 | · | |
| Quick Ratio | 16.4 | 20.6 | 8.6 | 8.7 | 16.5 | 24.4 | 30.2 | · | |
| Interest Coverage | · | · | -4631.9 | · | · | · | -70959.0 | · |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | · | · | · | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $17.10 | $20.89 | $14.51 | $2.21 | $3.36 | $4.53 | $3.73 | · | |
| Revenue / Share | $0.00 | $0.05 | · | $0.03 | · | · | · | · | |
| Cash Flow / Share | $-3.62 | $-4.02 | · | $-0.83 | $-0.86 | · | · | · | |
| Cash / Share | $6.70 | $9.19 | $11.56 | $0.89 | $3.36 | $4.56 | $3.77 | · | |
| EPS (TTM) | $-4.24 | $-4.28 | $-60.79 | $-1.04 | $-1.10 | $-0.64 | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $925.0K | $0 | · | · | · | · | $25M | |
| Net Income TTM | $-90M | $-75M | $-36M | $-55M | $-61M | $-33M | $-69M | $-32M | |
| Market Cap | $319M | $340M | $249M | $434M | $4.09B | $11.90B | $9.36B | · | |
| P/E | -4.9 | -5.3 | -0.3 | -9.8 | -87.6 | -440.6 | · | · | |
| P/S | · | 367.1 | · | · | · | · | · | · | |
| P/B | 1.2 | 1.1 | 1.3 | 4.6 | 28.6 | 62.2 | 66.1 | · | |
| P / Tangible Book | 1.2 | 1.1 | 1.3 | · | · | 62.3 | · | · | |
| P / Cash Flow | -4.1 | -4.8 | -4.8 | -9.5 | -86.1 | -484.2 | -608.2 | · | |
| P / FCF | -4.1 | -4.8 | -4.8 | -9.3 | -80.5 | -444.1 | -575.3 | · | |
| Earnings Yield | -20.6% | -18.7% | -313.7% | -10.2% | -1.1% | -0.23% | · | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $0 | $0 | · | $0 | $0 | $925.0K | · | $0 | $0 | $0 | · | · | · | |
| R&D Expense | $25M | $25M | $21M | $17M | $19M | $18M | $15M | $16M | $16M | $14M | $12M | $12M | $10M | $10M | $16M | $9M | |
| SG&A Expense | $11M | $8M | $7M | $7M | $7M | $8M | $6M | $6M | $5M | $5M | $3M | $4M | $2M | $3M | $-5M | $4M | |
| Operating Expenses | $37M | $33M | $28M | $24M | $26M | $26M | $22M | $22M | $21M | $19M | $15M | $15M | $13M | $13M | $12M | $14M | |
| Operating Income | $-37M | $-33M | $-28M | $-24M | $-26M | $-26M | $-22M | $-22M | $-20M | $-19M | $-15M | $-15M | $-13M | $-13M | $-12M | $-14M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $3.0K | · | · | · | $2.0K | · | · | |
| Interest Income | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $781.0K | $650.0K | $743.0K | $777.0K | · | · | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $-14.0K | · | $-22.0K | |
| Net Income | $-34M | $-31M | $-25M | $-21M | $-22M | $-23M | $-20M | $-20M | $-18M | $-17M | $2M | $-15M | $-12M | $-12M | $-11M | $-13M | |
| EPS (Basic) | $-1.53 | $-1.39 | $-1.12 | $-0.99 | $-1.05 | $-1.08 | $-1.00 | $-1.19 | $-1.09 | $-1.00 | · | $-32.67 | $-26.68 | $-0.26 | · | $-1.18 | |
| EPS (Diluted) | $-1.53 | $-1.39 | $-1.12 | $-0.99 | $-1.05 | $-1.08 | $-1.00 | $-1.19 | $-1.09 | $-1.00 | · | $-32.67 | $-26.68 | $-0.26 | · | $-1.18 | |
| Shares (Basic) | 22,552,032 | 22,305,734 | · | 21,168,431 | 21,055,378 | 20,996,287 | · | 16,953,443 | 16,941,524 | 16,903,735 | · | 446,255 | 444,465 | 55,420,912 | · | 11,050,207 | |
| Shares (Diluted) | 22,552,032 | 22,305,734 | · | 21,168,431 | 21,055,378 | 20,996,287 | · | 16,953,443 | 16,941,524 | 16,903,735 | · | 446,255 | 444,465 | 55,420,912 | · | 11,050,207 | |
| EBITDA | $-37M | $-33M | · | $-23M | $-25M | $-25M | · | $-21M | $-19M | $-18M | · | $-6M | $-3M | $-15M | · | $-14M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $112M | $124M | $104M | $71M | $59M | $71M | $137M | $67M | $111M | $150M | $148M | $25M | $31M | $35M | $82M | $40M | |
| Short-term Investments | $113M | $119M | $165M | $194M | $216M | $222M | $176M | $72M | $43M | $19M | $49M | · | · | · | $0 | · | |
| Prepaid Expense | $4M | $4M | $3M | $5M | $4M | $4M | $4M | $5M | $5M | $5M | $3M | · | · | · | $3M | · | |
| Other Current Assets | $132.0K | $181.0K | $168.0K | $208.0K | $970.0K | $997.0K | $981.0K | $2M | $2M | $1M | $1M | $1M | $2M | $2M | $630.0K | $2M | |
| Current Assets | $229M | $247M | $272M | $271M | $279M | $296M | $316M | $144M | $159M | $174M | $200M | $80M | $84M | $86M | $85M | $109M | |
| PP&E (Net) | $12M | $13M | $13M | $13M | $14M | $15M | $15M | $16M | $16M | $16M | $17M | $484.0K | $561.0K | $2M | $20M | $6M | |
| PP&E (Gross) | $28M | $27M | $27M | $27M | $27M | $27M | $27M | $26M | $26M | $25M | $25M | · | · | · | $25M | · | |
| Accum. Depreciation | $16M | $15M | $14M | $13M | $13M | $12M | $11M | $10M | $10M | $9M | $8M | · | · | · | $5M | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Other Non-current Assets | $1M | $1M | $1M | $1M | $1M | $896.0K | $975.0K | $789.0K | $794.0K | $743.0K | $764.0K | $524.0K | $529.0K | $905.0K | $0 | $2M | |
| Total Assets | $244M | $263M | $289M | $288M | $297M | $315M | $336M | $164M | $180M | $195M | $223M | $90M | $94M | $98M | $109M | $127M | |
| Accounts Payable | $3M | $5M | $2M | $2M | $2M | $3M | $1M | $2M | $2M | $2M | $3M | $4M | $3M | $5M | $625.0K | $9M | |
| Accrued Liabilities | $15M | $11M | $11M | $9M | $9M | $7M | $10M | $10M | $7M | $7M | $17M | · | · | · | $5M | · | |
| Current Liabilities | $22M | $19M | $16M | $15M | $15M | $14M | $15M | $16M | $13M | $12M | $23M | $5M | $5M | $7M | $7M | $10M | |
| Capital Leases | $5M | $6M | $7M | $7M | $8M | $9M | $9M | $10M | $11M | $12M | $12M | $9M | $10M | $10M | $4M | $11M | |
| Other Non-current Liabilities | $0 | $0 | $51.0K | $51.0K | $51.0K | $51.0K | $51.0K | $51.0K | $51.0K | $203.0K | $203.0K | · | · | · | $0 | · | |
| Total Liabilities | $27M | $25M | $24M | $22M | $24M | $24M | $25M | $27M | $25M | $25M | $37M | $14M | $14M | $17M | $11M | $21M | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Paid-in Capital | $635M | $621M | $618M | $593M | $580M | $577M | $573M | $380M | $378M | $375M | $373M | $547M | $547M | $547M | $5M | $543M | |
| Retained Earnings | $-418M | $-384M | $-353M | $-328M | $-307M | $-285M | $-262M | $-243M | $-223M | $-204M | $-187M | $-472M | $-467M | $-465M | $-151M | $-438M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | · | $0 | $-13.0K | $18.0K | · | $-92.0K | |
| Stockholders' Equity | $217M | $238M | $265M | $266M | $273M | $292M | $310M | $137M | $155M | $171M | $186M | $75M | $80M | $81M | $-146M | $106M | |
| Liabilities + Equity | $244M | $263M | $289M | $288M | $297M | $315M | $336M | $164M | $180M | $195M | $223M | $90M | $94M | $98M | $109M | $127M | |
| Shares Outstanding | 15,830,504 | 15,615,786 | 15,489,800 | 14,775,285 | 14,269,264 | 14,929,566 | 14,854,725 | 13,010,867 | 12,989,208 | 12,860,995 | 12,823,665 | 8,805,284 | 44,021,429 | 42,818,346 | 0 | 42,594,602 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $813.0K | $847.0K | $694.0K | $800.0K | $800.0K | $749.0K | $781.0K | $800.0K | $800.0K | $814.0K | $850.0K | $800.0K | $800.0K | $812.0K | $2M | $323.0K | |
| Stock-based Comp | $8M | $4M | $3M | $3M | $3M | $4M | $2M | $2M | $2M | $1M | $355.0K | $-459.0K | $-514.0K | $293.0K | $-6M | $2M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | $0 | $142.0K | $2M | · | · | |
| Other Non-cash | · | $339.0K | · | · | · | $-3M | · | · | · | $-7M | · | · | · | $-349.0K | · | · | |
| Operating Cash Flow | $-24M | $-26M | $-17M | $-20M | $-19M | $-21M | $-17M | $-16M | $-16M | $-22M | $-17M | $-17M | $-10M | $-14M | $-18M | $-9M | |
| CapEx | $354.0K | $281.0K | $128.0K | $127.0K | $148.0K | $780.0K | $116.0K | $167.0K | $460.0K | $65.0K | $128.0K | $-358.0K | $-308.0K | $29.0K | $1M | $322.0K | |
| Investing Cash Flow | $6M | $46M | $30M | $22M | $7M | $-45M | $-103M | $-29M | $-24M | $30M | $26M | $-10M | $-11M | $-29.0K | $65M | $-28M | |
| Stock Issued | · | · | $21M | $10M | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $6M | $195.0K | $21M | $10M | $54.0K | $4.0K | $190M | $131.0K | $399.0K | $-7M | $94M | $-1M | $87.0K | $107.0K | $66M | $-52.0K | |
| Net Change in Cash | $-12M | $20M | $33M | $12M | $-12M | $-66M | $70M | $-44M | $-39M | $2M | $103M | $-29M | $-21M | $-13M | $114M | $-37M | |
| Free Cash Flow | · | $-26M | · | · | · | $-22M | · | · | · | $-22M | · | · | · | $-13M | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | -2176.7% | · | · | -533.9% | -312.5% | -1601.6% | · | -2434.5% | |
| Net Margin | · | · | · | · | · | · | · | · | -1999.1% | · | · | -433.9% | -212.5% | -1503.1% | · | -2338.5% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | -2090.2% | · | · | -533.9% | -312.5% | -1566.8% | · | -2434.5% | |
| ROA | -12.7% | -10.7% | · | -9.3% | -9.2% | -8.9% | · | -15.9% | -13.5% | -11.5% | · | -4.2% | -1.8% | -11.5% | · | -8.6% | |
| ROE | -14.1% | -11.7% | · | -10.4% | -10.3% | -9.8% | · | -19.0% | -15.8% | -13.4% | · | -5.0% | -2.1% | -13.4% | · | -10.0% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.6 | 13.1 | · | 18.4 | 18.1 | 21.0 | · | 9.1 | 12.2 | 14.7 | · | 15.3 | 17.2 | 12.0 | · | 10.6 | |
| Quick Ratio | 10.5 | 12.9 | · | 18.0 | 17.8 | 20.8 | · | 8.8 | 11.8 | 14.3 | · | 4.8 | 6.4 | 5.0 | · | 3.9 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -6259.7 | · | · | · | · | · | · |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | · | · | 0.0 | 0.0 | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $13.72 | $15.23 | · | $17.97 | $19.15 | $19.54 | · | $10.56 | $11.93 | $13.28 | · | $8.54 | $1.81 | $1.90 | · | $2.48 | |
| Revenue / Share | · | · | · | $0.00 | $0.00 | · | · | $0.00 | $0.05 | · | · | $0.09 | $0.02 | $0.02 | · | $0.01 | |
| Cash Flow / Share | · | $-1.17 | · | · | · | $-0.99 | · | · | · | $-1.28 | · | · | · | $-0.24 | · | · | |
| Cash / Share | $7.11 | $7.95 | · | $4.81 | $4.12 | $4.74 | · | $5.12 | $8.55 | $11.67 | · | $2.86 | $0.71 | $0.83 | · | $0.95 | |
| EPS (TTM) | $-5.03 | $-4.55 | · | $-4.12 | $-4.32 | $-4.36 | · | · | · | · | · | · | · | · | · | $-2.02 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-111M | $-99M | · | $-85M | $-84M | $-81M | · | $-53M | $-48M | $-41M | · | $-50M | $-48M | $-52M | · | $-59M | |
| Market Cap | $498M | $315M | · | $256M | $213M | $175M | · | $546M | $473M | $655M | · | $139M | $731M | $599M | · | $545M | |
| P/E | -6.3 | -4.4 | · | -4.2 | -3.5 | -2.7 | · | · | · | · | · | · | · | · | · | -6.3 | |
| P/B | 2.3 | 1.3 | · | 1.0 | 0.8 | 0.6 | · | 4.0 | 3.0 | 3.8 | · | 1.8 | 9.2 | 7.4 | · | 5.2 | |
| P / Tangible Book | 2.3 | 1.3 | · | 1.0 | 0.8 | 0.6 | · | 4.0 | 3.0 | 3.8 | · | 1.8 | 9.2 | 7.4 | · | 5.2 | |
| P / Cash Flow | · | -12.1 | · | · | · | -8.4 | · | · | · | -30.2 | · | · | · | -46.0 | · | · | |
| Earnings Yield | -16.0% | -22.6% | · | -23.8% | -28.9% | -37.2% | · | · | · | · | · | · | · | · | · | -15.8% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | $0 | $925.0K | $0 | · | · |
| Margine Operativo % | · | -8930.3% | · | -3735.6% | · |
| Utile netto | $-90M | $-75M | $-36M | $-55M | $-61M |
| EPS Diluito | $-4.24 | $-4.28 | · | $-1.04 | $-1.10 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rapporto corrente | 16.6 | 20.8 | 8.7 | 9.0 | 16.7 |
| Quick Ratio | 16.4 | 20.6 | 8.6 | 8.7 | 16.5 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-78M | $-71M | $-52M | $-47M | $-51M |
Proprietari istituzionali (13F) 120 filer · $562.1M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
120
Valore detenuto
$562.1M
Nuove posizioni
21
Posizioni chiuse
4
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 21 (-3 vs trimestre precedente) | 4 (-7 vs trimestre precedente) | 39 (-5 vs trimestre precedente) | 33 (+18 vs trimestre precedente) | +272K |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| SAMSARA BIOCAPITAL, LLC | $54.003.644 | 1.717.127 | 9,61% | Azioni |
| Casdin Capital, LLC | $48.601.603 | 1.545.361 | 8,65% | Azioni |
| Redmile Group, LLC | $44.413.659 | 1.412.199 | 7,90% | Azioni |
| RTW INVESTMENTS, LP | $42.849.241 | 1.362.456 | 7,62% | Azioni |
| EcoR1 Capital, LLC | $39.983.706 | 1.271.342 | 7,11% | Azioni |
| BlackRock, Inc. | $33.273.565 | 1.057.983 | 5,92% | Azioni |
| BAKER BROS. ADVISORS LP | $31.188.682 | 991.691 | 5,55% | Azioni |
| Balyasny Asset Management L.P. | $25.748.307 | 818.706 | 4,58% | Azioni |
| Trails Edge Capital Partners, LP | $22.483.133 | 714.885 | 4,00% | Azioni |
| TORONTO DOMINION BANK | $21.428.049 | 681.337 | 3,81% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $16.873.711 | 536.525 | 3,00% | Azioni |
| JENNISON ASSOCIATES LLC | $16.309.405 | 518.582 | 2,90% | Azioni |
| VANGUARD GROUP INC | $13.525.383 | 656.572 | 2,41% | Azioni |
| CITADEL ADVISORS LLC | $12.862.484 | 408.982 | 2,29% | Azioni |
| GREAT POINT PARTNERS LLC | $11.076.061 | 352.180 | 1,97% | Azioni |
| ArrowMark Colorado Holdings LLC | $10.770.147 | 342.453 | 1,92% | Azioni |
| FMR LLC | $9.295.393 | 295.561 | 1,65% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $9.222.612 | 293.182 | 1,64% | Azioni |
| STATE STREET CORP | $7.054.927 | 224.322 | 1,26% | Azioni |
| FRANKLIN RESOURCES INC | $6.424.606 | 204.280 | 1,14% | Azioni |
| MORGAN STANLEY | $6.029.719 | 191.724 | 1,07% | Azioni |
| UBS Group AG | $5.387.039 | 171.289 | 0,96% | Azioni |
| BLAIR WILLIAM & CO/IL | $4.620.162 | 146.905 | 0,82% | Azioni |
| Driehaus Capital Management LLC | $4.513.956 | 143.528 | 0,80% | Azioni |
| Point72 Asset Management, L.P. | $4.463.384 | 141.920 | 0,79% | Azioni |
| MOORE CAPITAL MANAGEMENT, LP | $4.454.452 | 141.636 | 0,79% | Azioni |
| Rock Springs Capital Management LP | $3.357.288 | 106.750 | 0,60% | Azioni |
| DEUTSCHE BANK AG\ | $3.354.457 | 106.660 | 0,60% | Azioni |
| NORTHERN TRUST CORP | $3.259.509 | 103.641 | 0,58% | Azioni |
| GOLDMAN SACHS GROUP INC | $3.185.131 | 101.276 | 0,57% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3.006.651 | 95.601 | 0,53% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.905.980 | 92.400 | 0,52% | Opzione Call |
| DAFNA Capital Management LLC | $2.800.056 | 89.032 | 0,50% | Azioni |
| Woodline Partners LP | $2.636.611 | 83.835 | 0,47% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $2.335.540 | 74.262 | 0,42% | Azioni |
| Trexquant Investment LP | $2.319.815 | 73.762 | 0,41% | Azioni |
| JPMORGAN CHASE & CO | $1.997.551 | 61.882 | 0,36% | Azioni |
| XTX Topco Ltd | $1.743.085 | 55.424 | 0,31% | Azioni |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $1.688.244 | 52.300 | 0,30% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $1.343.984 | 42.734 | 0,24% | Azioni |
| Raiffeisen Bank International AG | $1.097.520 | 34.000 | 0,20% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.029.736 | 32.742 | 0,18% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $1.026.150 | 32.628 | 0,18% | Azioni |
| WELLINGTON MANAGEMENT GROUP LLP | $987.310 | 31.393 | 0,18% | Azioni |
| Bank of New York Mellon Corp | $903.897 | 28.741 | 0,16% | Azioni |
| Nuveen, LLC | $875.065 | 27.824 | 0,16% | Azioni |
| CITADEL ADVISORS LLC | $839.715 | 26.700 | 0,15% | Opzione Call |
| JANE STREET GROUP, LLC | $820.499 | 26.089 | 0,15% | Azioni |
| Quadrature Capital Ltd | $764.864 | 24.320 | 0,14% | Azioni |
| AMERICAN CENTURY COMPANIES INC | $733.729 | 23.330 | 0,13% | Azioni |
Attivisti e proprietari del 5%+ 4 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Rachel McMinn, Ph.D. | 21 Dicembre 2023 | · | Deposito iniziale | Investimento passivo | SEC |
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker ×18 depositi | 20 Dicembre 2023 | · | Deposito iniziale | M&A / vendita | SEC |
| Redmile Group, LLC, Jeremy C. Green | 27 Luglio 2023 | · | Deposito iniziale | M&A / vendita | SEC |
| Jonathan G. Drachman | 27 Dicembre 2019 | · | Deposito iniziale | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 37 insider · 18 dirigenti · 18 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Rachel Mcminn | Chief Executive Officer | 22 Settembre 2026 M | 1.345.063 | 0 | 1 | $-73.979 |
| Jonathan G Drachman | President and CEO | 02 Agosto 2022 A | 25.000 | 0 | 0 | $0 |
| David Main | President and CEO | 07 Agosto 2018 A | 71.530 | 0 | 0 | $0 |
| Christine Mikail Cvijic | President and CFO | 07 Luglio 2026 S | 84.040 | 0 | 12 | $-900.010 |
| Sean Michael Smith | Interim CFO, Prin Acct Off | 10 Agosto 2023 M | 21.637 | 0 | 0 | $0 |
| Robert Ho | Chief Financial Officer | 01 Febbraio 2022 A | 21.503 | 0 | 0 | $0 |
| Kamran Alam | CFO, Vice President Finance | 07 Agosto 2018 A | 0 | 0 | 0 | $0 |
| Lloyd Mackenzie | Chief Operating Officer | 07 Agosto 2018 A | 0 | 0 | 0 | $0 |
| Christina Shafer | Chief Commercial Officer | 05 Maggio 2026 A | · | 0 | 0 | $0 |
| Julie Jordan | Chief Medical Officer | 26 Marzo 2026 S | 12.472 | 0 | 1 | $-18.125 |
| Stuart Cobb | Chief Scientific Officer | 13 Marzo 2026 S | 30.497 | 0 | 3 | $-141.446 |
| Donna Cochener | General Counsel, SVP Legal | 02 Agosto 2022 A | · | 0 | 0 | $0 |
| Carl Walkey | Senior Vice President | 02 Agosto 2022 A | 1.352.489 | 0 | 0 | $0 |
| Holly Vance | General Counsel | 03 Agosto 2021 A | · | 0 | 0 | $0 |
| Shelley Mccloskey | VP, HR and Administration | 07 Agosto 2018 A | · | 0 | 0 | $0 |
| Abigail Jenkins | Chief Commercial Officer | 09 Marzo 2018 A | · | 0 | 0 | $0 |
| David Chilton Mitchell | VP Global Regulatory & Quality | 08 Marzo 2017 A | 3.575 | 0 | 0 | $0 |
| Stephen B Shrewsbury | CMO; Senior VP Clinical Dev. | 10 Marzo 2016 A | · | 0 | 0 | $0 |
| Cory S. Freedland | Direttore | 20 Febbraio 2026 A | · | 0 | 0 | $0 |
| Sarah B. Noonberg | Direttore | 20 Febbraio 2026 A | · | 0 | 0 | $0 |
| Rohan Palekar | Direttore | 20 Febbraio 2026 A | · | 0 | 0 | $0 |
| Robert Keith Woods | Direttore | 12 Giugno 2025 A | · | 0 | 0 | $0 |
| Keith Woods | Direttore | 16 Gennaio 2024 A | · | 0 | 0 | $0 |
| Erin Lavelle | Direttore | 08 Giugno 2023 A | · | 0 | 0 | $0 |
| Martin Babler | Direttore | 08 Giugno 2023 A | · | 0 | 0 | $0 |
| Todd E Simpson | Direttore | 08 Giugno 2023 A | · | 0 | 0 | $0 |
| Erin M. Lavelle | Direttore | 11 Maggio 2021 A | · | 0 | 0 | $0 |
| Lewis T Williams | Direttore | 11 Maggio 2021 A | · | 0 | 0 | $0 |
| Sean P. Nolan | Direttore | 05 Maggio 2020 A | · | 0 | 0 | $0 |
| Daniel J Levitt | Direttore | 14 Maggio 2018 M | 0 | 0 | 0 | $0 |
| Gary Bridger | Direttore | 07 Maggio 2018 A | 0 | 0 | 0 | $0 |
| Robert Pelzer | Direttore | 07 Maggio 2018 A | · | 0 | 0 | $0 |
| Pfizer Inc. | Proprietario del 10% | 10 Agosto 2015 S | 975.403 | 0 | 0 | $0 |
| Ventures West 8 Limited Partnership | Proprietario del 10% | 12 Marzo 2014 C | 1.543.989 | 0 | 0 | $0 |
| Robert Baffi | · | 20 Febbraio 2026 A | · | 0 | 0 | $0 |
| Patel Priti | · | 31 Marzo 2023 M | 37.313 | 0 | 0 | $0 |
| Barbara Troupin | · | 09 Marzo 2018 A | · | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 20 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,76% | 10.681 NS | 31 Luglio 2026 | N-PORT |
| IBRN · iShares Trust | 0,48% | 986 SH | 11 Settembre 2026 | Giornaliero |
| IWC · iShares Trust | 0,10% | 38.527 SH | 11 Settembre 2026 | Giornaliero |
| IBB · iShares Trust | 0,04% | 120.007 SH | 11 Settembre 2026 | Giornaliero |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,04% | 1.426 SH | 01 Ottobre 2026 | Giornaliero |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 9.854 SH | 19 Agosto 2026 | Giornaliero |
| IWM · iShares Trust | 0,01% | 290.868 SH | 11 Settembre 2026 | Giornaliero |
| RSSL · Global X Funds | 0,01% | 5.395 NS | 31 Luglio 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 65.030 SH | 19 Agosto 2026 | Giornaliero |
| DFAS · Dimensional ETF Trust | 0,00% | 12.679 NS | 31 Luglio 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 400 NS | 31 Luglio 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 1.381 NS | 31 Luglio 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 4.511 SH | 03 Settembre 2026 | Giornaliero |
| DFAC · Dimensional ETF Trust | 0,00% | 3.984 NS | 31 Luglio 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 796 NS | 31 Luglio 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 126.680 SH | 19 Agosto 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 397.791 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 722 SH | 19 Agosto 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,00% | 19.995 SH | 19 Agosto 2026 | Giornaliero |
| IWN · iShares Trust | · | 104.527 SH | 11 Settembre 2026 | Giornaliero |
NGNE Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 15 analisti
COMPRA
Target mediano
$65.00
+153,4%
6 40,0%
Acquisto forte
8 53,3%
Compra
1 6,7%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
7 analisti · 2026-10-03Target medio $80.43 +213,6%
← Sotto tutti i target
Prezzo attuale $25.65
Basso$46.00
Media$80.43
Alto$166.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| NGNE | $319M | -4.9 | · | · | -33.6% | · |
| ZURA | · | · | · | · | · | · |
| ALLO | $314M | -1.6 | -76.8% | · | -59.9% | · |
| PROK | · | · | 1075.0% | -7725.2% | 6.9% | · |
| MNPR | · | · | · | · | · | · |
| CAPR | $1.66B | -12.8 | -11.6% | · | -51.1% | · |
| PBYI | $300M | 9.8 | -0.91% | 13.6% | 26.5% | · |
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | · |
| OVID | $212M | -4.0 | 1181.3% | -240.1% | -18.7% | · |
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | · |
| TECX | $391M | -5.2 | · | · | -27.7% | · |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 11, 2026